These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


86 related items for PubMed ID: 6659567

  • 1. [Modification of pathologic fatty acid patterns in old age by combined clofibrinic and nicotinic acid treatment].
    Reuter W.
    Z Alternsforsch; 1983; 38(5):383-8. PubMed ID: 6659567
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Effect of clofibric acid on fatty acid metabolism in HLP patients in the 2d half of life].
    Reuter W.
    Z Alternsforsch; 1982; 37(6):409-16. PubMed ID: 7164480
    [Abstract] [Full Text] [Related]

  • 4. [Effect of combination therapy of clofibric acid and nicotinic acid derivatives on fatty acid metabolism in hyperlipoproteinemia].
    Reuter W.
    Z Gesamte Inn Med; 1982 Oct 15; 37(20):682-8. PubMed ID: 6818779
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Fatty acid metabolism in primary hyperlipoproteinemia (HLP) (author's transl)].
    Reuter W.
    Dtsch Z Verdau Stoffwechselkr; 1979 Oct 15; 39(3):124-9. PubMed ID: 520271
    [Abstract] [Full Text] [Related]

  • 7. Changes in lipids and lipoproteins in patients with hyperlipidemia type IIb, IV and V treated with different lipid lowering drugs.
    Hutt V, Wechsler JG, Klör HU, Ditschuneit H.
    Artery; 1980 Oct 15; 8(2):113-9. PubMed ID: 7458676
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Plafibride treatment of hyperlipidemias type II and IV].
    Soler J, Vinzia C, Gómez JM, Morató J.
    Med Clin (Barc); 1984 May 19; 82(19):840-2. PubMed ID: 6738212
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical experience with bezafibrate.
    Schubotz R, Schneider J, Hausmann L, Mühlfellner G, Mühlfellner O, Kaffarnik H.
    Artery; 1980 May 19; 8(6):553-9. PubMed ID: 7259534
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types].
    Noseda G, Fragiacomo C, Weidmann P, Bachmann C.
    Schweiz Med Wochenschr; 1980 Dec 06; 110(49):1875-7. PubMed ID: 7455660
    [Abstract] [Full Text] [Related]

  • 14. Pirifibrate in the treatment of hyperlipoproteinemia: types IIa, IIb, and IV.
    Lopez Rodriguez J, Martorell J.
    Clin Ther; 1980 Dec 06; 3(4):234-41. PubMed ID: 7273061
    [Abstract] [Full Text] [Related]

  • 15. [Lipid-reducing basic diet and serum fatty acid levels].
    Reuter W.
    Z Gesamte Inn Med; 1980 Sep 15; 35(18):701-6. PubMed ID: 7445612
    [Abstract] [Full Text] [Related]

  • 16. [Efficacy of bezafibrate and fenofibrate on elevated blood lipids in HLP type IIa, IIb and IV].
    Schwartzkopff W, Luley C, Scheffler W, Lehmann-Leo W, Schilling A, Wegscheider K.
    Med Welt; 1982 Apr 30; 33(17):631-7. PubMed ID: 7098826
    [No Abstract] [Full Text] [Related]

  • 17. Lipids and lipoproteins in hyperlipidemia type IIa during treatment with different lipid lowering drugs.
    Wechsler JG, Hutt V, Klör HU, Ditschuneit H.
    Artery; 1980 Apr 30; 8(6):519-29. PubMed ID: 7259531
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Indications for and the therapeutic action of hypolipidemic agents in patients with hyperlipoproteinemias].
    Goranov I, Naumova R, Kerekovska M, Balabanski L.
    Vutr Boles; 1987 Apr 30; 26(1):96-101. PubMed ID: 3590738
    [Abstract] [Full Text] [Related]

  • 20. [Comparison of the lipid-lowering agents clofibrate and bezafibrate in patients with hyperlipoproteinemias IIa and IIb].
    Kokot F, Szczechowska E.
    Z Gesamte Inn Med; 1981 Jul 01; 36(13):454-7. PubMed ID: 7025475
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.